Singular Genomics Systems, Inc. (NasdaqCM: OMIC) Loss Submission Form

Kuznicki Law is investigating the proposed sale of Singular Genomics Systems, Inc. (NasdaqCM: OMIC) to an affiliate of Deerfield Management Company, L.P.  Under the terms of the proposed transaction, shareholders of Singular will receive $20.00 in cash for each share of Singular that they own. Kuznicki Law is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.